UroGen Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Mar 24 | SellUS$168,600 | Mark Schoenberg | Individual | 12,000 | US$14.05 | |
01 Feb 24 | SellUS$78,790 | Jason Smith | Individual | 4,993 | US$15.78 | |
01 Feb 24 | SellUS$59,790 | Mark Schoenberg | Individual | 3,789 | US$15.78 | |
28 Jul 23 | BuyUS$15,000,000 | Monograph Capital Partners | Company | 1,572,327 | US$9.54 |
Insider Trading Volume
Insider Buying: URGN insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,691 | 0.00496% |
Hedge Funds | 1,726,808 | 5.06% |
Individual Insiders | 2,318,053 | 6.79% |
VC/PE Firms | 5,703,975 | 16.7% |
General Public | 6,602,095 | 19.3% |
Institutions | 17,769,465 | 52.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 45.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,083,430 | US$44.8m | 108% | 0.59% | |||
2,620,545 | US$38.1m | 0% | 5.24% | |||
2,303,031 | US$33.5m | 0% | 0.21% | |||
1,726,808 | US$25.1m | 101% | 0.43% | |||
1,719,304 | US$25.0m | 43.6% | no data | |||
1,572,327 | US$22.8m | 0% | no data | |||
1,487,669 | US$21.6m | 0% | 6.68% | |||
1,369,315 | US$19.9m | 0% | no data | |||
1,200,000 | US$17.4m | 13.2% | 0.01% | |||
870,045 | US$12.6m | -0.02% | 0.13% | |||
648,302 | US$9.4m | 0% | 0.08% | |||
525,404 | US$7.6m | 3.25% | 2.2% | |||
495,606 | US$7.2m | 0% | 1.41% | |||
490,831 | US$7.1m | 8.09% | no data | |||
444,798 | US$6.5m | 823% | no data | |||
426,506 | US$6.2m | 54.7% | 0.01% | |||
425,932 | US$6.2m | 0% | 0.36% | |||
408,693 | US$5.9m | 0% | no data | |||
326,941 | US$4.8m | 0% | no data | |||
320,000 | US$4.6m | 0% | 1.12% | |||
312,516 | US$4.5m | 42.6% | no data | |||
255,430 | US$3.7m | 0% | 3.27% | |||
250,600 | US$3.6m | -34.2% | 0.13% | |||
235,236 | US$3.4m | 32.6% | no data | |||
212,000 | US$3.1m | -0.28% | no data |